Even at Stage IV, Immunotherapy Helps in Pancreatic Cancer
(MedPage Today) -- CHICAGO -- Real-world data demonstrate that immunotherapies, broadly defined, prolong survival in stage IV pancreatic cancer compared with standard care, a researcher said here.
Records from the U.S. National Cancer Database...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Cancer | Cancer & Oncology | Databases & Libraries | Gastroenterology | Immunotherapy | Pancreas | Pancreatic Cancer